Dinotefuran aggravates Alzheimer's disease-associated microglial inflammation through the CHUK/NFKB1-mediated NF-κB signaling pathway

Neurotherapeutics · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles